Characterization of Donor Variability for γδ T Cell ex vivo Expansion and Development of an Allogeneic γδ T Cell Immunotherapy

Gamma delta (γδ) T cells recently emerged as an attractive candidate for cancer immunotherapy treatments due to their inherent cytotoxicity against both hematological and solid tumors. Moreover, γδ T cells provide a platform for the development of allogeneic cell therapies, as they can recognize ant...

Descripción completa

Detalles Bibliográficos
Autores principales: Burnham, Rebecca E., Zoine, Jaquelyn T., Story, Jamie Y., Garimalla, Swetha N., Gibson, Greg, Rae, Aaron, Williams, Erich, Bixby, Lisa, Archer, David, Doering, Christopher B., Spencer, H. Trent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691424/
https://www.ncbi.nlm.nih.gov/pubmed/33282892
http://dx.doi.org/10.3389/fmed.2020.588453

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691424/
https://www.ncbi.nlm.nih.gov/pubmed/33282892
http://dx.doi.org/10.3389/fmed.2020.588453

Ejemplares similares